Tata India Pharma & Healthcare Fund-Direct Plan-Growth

As on 16 May 2025

Tata India Pharma & Healthcare Fund-Direct Plan-Growth

Q: What kind of returns does Tata India Pharma & Healthcare Fund-Direct Plan-Growth provide?

Tata India Pharma & Healthcare Fund-Direct Plan-Growth aims to generate capital appreciation by investing mainly in public sector undertakings (PSUs). Historically, its returns have often shown moderate to high growth rate depending on market conditions. Tata India Pharma & Healthcare Fund-Direct Plan-Growth had a return of 18.34% over the past 1 year.

Q: How much expense ratio is charged by Tata India Pharma & Healthcare Fund-Direct Plan-Growth?

The expense ratio for Tata India Pharma & Healthcare Fund-Direct Plan-Growth, or any other mutual fund, is the yearly fee you pay for managing your investments. As of 16 May 2025, the expense ratio charged by Tata India Pharma & Healthcare Fund-Direct Plan-Growth is typically around 0.1 %. This fee covers fund management, administrative, and other operational costs. It is relatively low compared to actively managed funds, reflecting its direct growth option.

Q: What is the AUM of Tata India Pharma & Healthcare Fund-Direct Plan-Growth?

As of 16 May 2025, the Assets Under Management (AUM) of Tata India Pharma & Healthcare Fund-Direct Plan-Growth is approximately ₹1222.721 crore. The AUM can fluctuate based on market conditions and investor activity. It indicates the total value of assets managed by the fund.

Q: What is the NAV of Tata India Pharma & Healthcare Fund-Direct Plan-Growth?

The Net Asset Value (NAV) of Tata India Pharma & Healthcare Fund-Direct Plan-Growth is updated daily and reflects the per-unit value of the fund's assets. As of 16 May 2025 , the NAV is around undefined per unit, but this value might change based on market performance and fund holdings.

Q: What is the PE and PB ratio of Tata India Pharma & Healthcare Fund-Direct Plan-Growth?

The PE ratio for Tata India Pharma & Healthcare Fund-Direct Plan-Growth is 47.01 and the PB ratio is 7.13. The PE ratio is calculated by dividing the market price by the earnings per share, whereas the PB ratio is calculated by dividing the stock price by the book value per share.

Q: What is the exit load of Tata India Pharma & Healthcare Fund-Direct Plan-Growth?

The exit load for Tata India Pharma & Healthcare Fund-Direct Plan-Growth is 0% if units are redeemed within 30 days from the date of investment. After this period, no exit load is applicable. This fee is charged to discourage short-term trading and ensure long-term investment.

Equity

NAV

₹ 34.31

CAGR (3 Years)

25.45%

AUM (Cr)

₹ 1,222.72

Risk

Very High Risk

About Tata India Pharma & Healthcare Fund-Direct Plan-Growth

To seek long term capital appreciation by investing at least 80% of its net assets in equity/equity related instruments of the companies in the pharma & healthcare sector in India.

Breakdown of this Fund

Chemicals

0.88%

Debt Others

12.74%

Fertilizers

3.00%

Healthcare

63.58%

Insurance

3.32%

IT - Software

1.72%

Miscellaneous

1.54%

Pharmaceuticals

128.31%

Retail

2.31%

Market Capitalization

Expense Ratio, Exit Load and Tax

Expense Ratio

0.1

Exit Load

0.50% - If redeemed\switched out within 30 days from the date of allotment. Nil ...

Stamp Duty

0.005% (from July 1st, 2020)

Tax Implication

Returns are taxed at 20%, if you redeem before one year. After 1 year, you are required to pay LTCG tax of 12.5% on returns of Rs 1.25 lakh+ in a financial year.